Rebecca Korbal, PHARMD | |
116 Farmington Rd, Rochester, NH 03867-4352 | |
(603) 332-4300 | |
Not Available |
Full Name | Rebecca Korbal |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 116 Farmington Rd, Rochester, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285221176 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 5302413146 (Michigan) | Secondary |
183500000X | Pharmacist | PR70050 (Maine) | Secondary |
183500000X | Pharmacist | PHCY-01121 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rebecca Korbal, PHARMD 14 Back Cove Est, Portland, ME 04103-4600 Ph: () - | Rebecca Korbal, PHARMD 116 Farmington Rd, Rochester, NH 03867-4352 Ph: (603) 332-4300 |
News Archive
In a study published by the journal Nature on Sunday, scientists evaluated breast cancer from a genetic perspective and found distinct genetic differences in patients' tumors. The results of the research point to the fact that analyzing genetics is not only helpful for cancer research, but imperative. Based on the study, scientists conclude that breast cancer can be broken down into four different subtypes.
In addition to sickening and taking the lives of millions across the globe, COVID-19 complicated patient care in a range of less-direct ways, from increased incidence of heart attacks to decreased cancer screenings.
White blood cells are part of many immune system responses in the human body. New research shows that a specific type of those cells may cause brain cancer tissues to die – but that's not good news, according to researchers at Penn State College of Medicine and Penn State Cancer Institute.
Moores UCSD Cancer Center at the University of California, San Diego has been designated a Breast Imaging Center of Excellence by the American College of Radiology.
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
› Verified 5 days ago
Christina Carroll, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 116 Farmington Rd, Rochester, NH 03867 Phone: 603-332-5540 | |
Roger D Ealy Sr., Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 116 Farmington Rd, Rochester, NH 03867 Phone: 603-332-8438 Fax: 603-332-8438 | |
Mrs. Susan C Burke, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 S Main St, Rochester, NH 03867 Phone: 603-332-9360 | |
Stephanie Gisis, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 S Main St, Rochester, NH 03867 Phone: 603-332-9360 Fax: 603-332-8925 | |
Philip Lee Canter, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 Milton Rd, Rochester, NH 03868 Phone: 603-335-7851 | |
Mrs. Thoa Ngoc Pham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 S Main St, Rochester, NH 03867 Phone: 603-332-9360 | |
Dr. John J Moro Iv, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 N Main St, Rochester, NH 03867 Phone: 603-332-6497 |